296 related articles for article (PubMed ID: 26050196)
21. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1.
Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
23. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
[TBL] [Abstract][Full Text] [Related]
24. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
25. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells.
Lotz M; Ranheim E; Kipps TJ
J Exp Med; 1994 Mar; 179(3):999-1004. PubMed ID: 8113691
[TBL] [Abstract][Full Text] [Related]
26. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
Porakishvili N; Memon A; Vispute K; Kulikova N; Clark EA; Rai KR; Nathwani A; Damle RN; Chiorazzi N; Lydyard PM
Br J Haematol; 2011 May; 153(4):486-98. PubMed ID: 21443749
[TBL] [Abstract][Full Text] [Related]
27. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
28. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of purified malignant B cells induced by PMA or by activated normal T cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Leukemia; 1993 Oct; 7(10):1576-84. PubMed ID: 8105156
[TBL] [Abstract][Full Text] [Related]
30. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
[TBL] [Abstract][Full Text] [Related]
32. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
[TBL] [Abstract][Full Text] [Related]
33. Nurse-like cells show deregulated expression of genes involved in immunocompetence.
Bhattacharya N; Diener S; Idler IS; Rauen J; Häbe S; Busch H; Habermann A; Zenz T; Döhner H; Stilgenbauer S; Mertens D
Br J Haematol; 2011 Aug; 154(3):349-56. PubMed ID: 21615384
[TBL] [Abstract][Full Text] [Related]
34. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
35. Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells.
Jahrsdörfer B; Wooldridge JE; Blackwell SE; Taylor CM; Griffith TS; Link BK; Weiner GJ
J Leukoc Biol; 2005 Mar; 77(3):378-87. PubMed ID: 15582984
[TBL] [Abstract][Full Text] [Related]
36. Surface membrane antigen expression changes induced in vitro by exogenous growth factors in chronic lymphocytic leukemia cells.
Vilpo J; Hulkkonen J; Hurme M; Vilpo L
Leukemia; 2002 Sep; 16(9):1691-8. PubMed ID: 12200683
[TBL] [Abstract][Full Text] [Related]
37. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective.
Darwiche W; Gubler B; Marolleau JP; Ghamlouch H
Front Immunol; 2018; 9():683. PubMed ID: 29670635
[TBL] [Abstract][Full Text] [Related]
38. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
[TBL] [Abstract][Full Text] [Related]
39. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
[TBL] [Abstract][Full Text] [Related]
40. New perspectives on the approach to chronic lymphocytic leukemia.
Goodman MG; Spinosa JC; Saven A; Piro LD; Wormsley S
Leuk Lymphoma; 1996 Jun; 22(1-2):1-10. PubMed ID: 8724523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
